A Novel Drug-Drug Salt of Naproxen and Vortioxetine: Synthesis, Characterization, and Solubility Study

被引:1
作者
Zhang, Xianrui [1 ]
Gao, Yuting [1 ]
机构
[1] Wuzhou Univ, Coll Food & Pharmaceut Engn, Wuzhou 543000, Peoples R China
关键词
CLINICAL PHARMACOKINETICS; COCRYSTAL; ACIDS; STABILITY; PAIN;
D O I
10.1155/2023/6678252
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Naproxen (NAP) is an aromatic propionic acid nonsteroidal anti-inflammatory drug, and vortioxetine (VOT) is a novel antidepressant drug. In this study, a new 1 : 1 drug-drug salt of NAP and VOT (namely, NAP-VOT) was designed and synthesized by liquid-assisted grinding and slow evaporation. The obtained salt was characterized by single-crystal X-ray diffraction, powder X-ray diffraction (PXRD), and differential scanning calorimetry (DSC). Single-crystal structure showed that NAP-VOT is a molecular salt. The NAP and VOT molecules in the salt were connected by N-H+MIDLINE HORIZONTAL ELLIPSISO hydrogen bonds between the carbonyl oxygen of NAP and the piperazine group of VOT. In addition, solubility and dissolution rate experiments were performed in water and pH 6.86 phosphate buffers, and the result suggested that salt formation could increase the solubility and dissolution rate of NAP and VOT in water. Furthermore, this study provides a new research idea to solve the problem of drug-drug combination by achieving drug-drug association at the molecular level.
引用
收藏
页数:8
相关论文
共 34 条
[1]   Physicomechanical, stability, and pharmacokinetic evaluation of aceclofenac dimethyl urea cocrystals [J].
Afzal, Hafsa ;
Abbas, Nasir ;
Hussain, Amjad ;
Latif, Sumera ;
Fatima, Kanwal ;
Arshad, Muhammad Sohail ;
Bukhari, Nadeem Irfan .
AAPS PHARMSCITECH, 2021, 22 (02)
[2]   Mechanochemical synthesis of brexpiprazole cocrystals to improve its pharmaceutical attributes [J].
Arabiani, Mohsin R. ;
Lodagekar, Anurag ;
Yadav, Balvant ;
Chavan, Rahul B. ;
Shastri, Nalini R. ;
Purohit, Parva Y. ;
Shelat, Pragna ;
Dave, Divyang .
CRYSTENGCOMM, 2019, 21 (05) :800-806
[3]   Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy Individuals [J].
Areberg, Johan ;
Petersen, Kamilla B. ;
Chen, Grace ;
Naik, Himanshu .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 (06) :552-559
[4]   PHARMACEUTICAL SALTS [J].
BERGE, SM ;
BIGHLEY, LD ;
MONKHOUSE, DC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (01) :1-19
[5]   A Novel, Extremely Bioavailable Cocrystal of Pterostilbene [J].
Bofill, Lidia ;
Barbas, Rafael ;
de Sande, Dafne ;
Font-Bardia, Merce ;
Rafols, Clara ;
Alberti, Joan ;
Prohens, Rafel .
CRYSTAL GROWTH & DESIGN, 2021, 21 (04) :2315-2323
[6]   Pharmaceutical paroxetine-based organic salts of carboxylic acids with optimized properties: the identification and characterization of potential novel API solid forms [J].
Carvalho, Paulo S., Jr. ;
Diniz, Luan F. ;
Tenorio, Juan C. ;
Souza, Matheus S. ;
Franco, Chris H. J. ;
Rial, Rafael C. ;
Warszawski de Oliveira, Karla Regina ;
Nazario, Carlos E. D. ;
Ellena, Javier .
CRYSTENGCOMM, 2019, 21 (24) :3668-3678
[7]   Vortioxetine: Clinical Pharmacokinetics and Drug Interactions [J].
Chen, Grace ;
Hojer, Astrid-Maria ;
Areberg, Johan ;
Nomikos, George .
CLINICAL PHARMACOKINETICS, 2018, 57 (06) :673-686
[8]   Lack of Effect of Multiple Doses of Vortioxetine on the Pharmacokinetics and Pharmacodynamics of Aspirin and Warfarin [J].
Chen, Grace ;
Zhang, Wencan ;
Serenko, Michael .
JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (06) :671-679
[9]   Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment [J].
Cryan, JF ;
Page, ME ;
Lucki, I .
PSYCHOPHARMACOLOGY, 2005, 182 (03) :335-344
[10]   Clinical pharmacokinetics of naproxen [J].
Davies, NM ;
Anderson, KE .
CLINICAL PHARMACOKINETICS, 1997, 32 (04) :268-293